This Regulation amends the approval periods of active substances listed in the Annex to the Regulation (EU) 540/2011, implementing Regulation (EC) 1107/2009 in order to extend the approval periods of several active substances.
As such, the approval periods of the following active substances have been extended as follows:

Haloxyfop-P, to 31 December 2023;
Napropamide, to…

Details on this legislative text is provided by Cedrec. Please click here to see the summary.